firefly luciferin has been researched along with B16 Melanoma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Fuentes, D; Gammon, ST; Liu, TW; Piwnica-Worms, D | 1 |
| Bibee, K; Sept, D; Sim, H; Wickline, S | 1 |
| Benoit, JP; Carmoy, N; David, S; Denis, C; Misery, L; Montier, T; Passirani, C; Pitard, B; Resnier, P | 1 |
3 other study(ies) available for firefly luciferin and B16 Melanoma
| Article | Year |
|---|---|
Multi-Modal Multi-Spectral Intravital Macroscopic Imaging of Signaling Dynamics in Real Time during Tumor-Immune Interactions.
Topics: Animals; Cell Communication; Firefly Luciferin; Genes, Reporter; Intravital Microscopy; Luciferases; Luminescent Measurements; Melanoma, Experimental; Mice, Inbred C57BL; Mice, Transgenic; Molecular Imaging; Neoplasms; Pancreas; Reproducibility of Results; Signal Transduction | 2021 |
Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy.
Topics: Animals; Antineoplastic Agents; Female; Firefly Luciferin; Luciferases, Firefly; Luminescent Measurements; Melanoma, Experimental; Mice; Models, Biological; Pharmacokinetics; Transfection | 2011 |
In vivo imaging of DNA lipid nanocapsules after systemic administration in a melanoma mouse model.
Topics: Animals; Benzothiazoles; Carbocyanines; DNA; Electrophoresis, Agar Gel; Fatty Acids, Monounsaturated; Female; Fluorescent Dyes; Ganciclovir; Gene Transfer Techniques; Genes, Transgenic, Suicide; Glycerol; Herpes Simplex; Humans; Lipids; Luciferases; Melanoma-Specific Antigens; Melanoma, Experimental; Mice; Mice, Nude; Molecular Imaging; Nanocapsules; Octoxynol; Oleic Acids; Particle Size; Phosphatidylethanolamines; Plasmids; Polyethylene Glycols; Quaternary Ammonium Compounds; Static Electricity; Stearic Acids; Surface Properties; Thymidine Kinase; Tissue Distribution; Treatment Outcome; Triglycerides; Xenograft Model Antitumor Assays | 2012 |